Status: In early 2022, supplies were used up.
Important Project Documentation
Use and Availability / Product Information
Supplies have been totally depleted due to accelerated use in the last four years.
This adenoviral reference material has been used in validating internal reference materials and assays for two decades. 5,000 vials were produced in 2001 by Introgen Therapeutics, with FDA/CBER involvement. Each 0.5 mL vial contained approximately 5 x 10E11 virus particles per mL.
NIST is collecting proposals for production and seeking government grants. FDA/CBER involvement is ongoing.